Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

http://www.wikidata.org/entity/Q47301630

about

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis Aripiprazole partial agonism at 5-HT2C: a comparison of weight gain associated with aripiprazole adjunctive to antidepressants with high versus low serotonergic activities Review of pharmacological treatment in mood disorders and future directions for drug development.Genetics of Common Antipsychotic-Induced Adverse Effects Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.Towards the clinical implementation of pharmacogenetics in bipolar disorder.Pharmacogenetics of antipsychotics.Genetic variations in the serotoninergic system contribute to body-mass index in Chinese adolescents.Antipsychotic drugs and obesity.A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction Personalized medicine in psychiatry: problems and promises.The promise and reality of pharmacogenetics in psychiatry Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies Correlates of weight gain during long-term risperidone treatment in children and adolescents Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain.Association Study of Fat-mass and Obesity-associated Gene and Body Mass Index in Japanese Patients with Schizophrenia and Healthy Subjects.Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine.No Association between Serotonin Receptor 2C-759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients.Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications The role of pharmacogenetics in treating central nervous system disorders.759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment.From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.Genetics of antipsychotic-induced side effects and agranulocytosis.Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review.Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Pharmacogenetics in psychiatry: translating research into clinical practice.Pharmacogenetics in schizophrenia: a review of clozapine studies.HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.Genetic Determinants of Clozapine-Induced Metabolic Side Effects.Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.Association between serotonin 5-HT-2C receptor gene (HTR2C) polymorphisms and obesity- and mental health-related phenotypes in a large population-based cohort.Addiction Research Centres and the Nurturing of Creativity. Substance abuse research in a modern health care centre: the case of the Centre for Addiction and Mental Health.Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.

P2860

Q24600775-226C5208-AFF0-4B8D-8B01-6A140768DCFA Q24615556-17E62AF1-EB11-458E-8592-10A30DB6207E Q26853509-0F35E015-F696-4840-A6F5-258A0E7A6769 Q28072893-05C8BB0C-9BE1-45A5-8BC2-3EC682C36BC8 Q33660225-E2D8C37D-503C-4F2F-9E68-C524C6A4E490 Q33688133-F9F95BE3-28B5-4481-A870-454BD63A4F44 Q33836837-FCC54FEF-5F4C-46AF-A2F5-40DE19FF3D11 Q34648230-2A1394C6-3D29-45DF-8B2C-FCB09E7403CC Q34648940-3635140B-EF67-49B4-A84C-9FD14B6E7B03 Q34660593-51639328-50DB-466E-8F6E-7829DB8B7F06 Q34676533-40A18A41-D5AC-4024-B038-3C5B7BBAEBDE Q34726454-944490A4-D5E5-4B5A-8B1A-50FA37107E41 Q35226451-5E3382C7-7EC7-4F23-B4A7-1A370C57B17D Q35771833-D7E0FD15-4CF3-4FCF-8689-9FE4C89C5416 Q36230583-964A738A-4838-48DB-A1D5-ED671C0C4AC5 Q36373562-220031DB-CD67-4F24-B927-F36EE15060D6 Q36441507-0F6141F0-909F-43FD-B2EE-E283EB4E6BEC Q36600861-548C0FD1-29BA-4C1A-82D1-15F9A46ACC88 Q36754038-EB0910AD-7740-47D2-9A16-FF02232A4BB4 Q36941595-3DEF1991-347D-4374-9890-D18A40EBCE6F Q36956632-40B88DDF-B525-4476-8F31-59B77DEF8E97 Q37220366-53C0149C-1C6C-44EA-B68B-8A0876ED9C95 Q37292132-B6CAD2B3-CC04-4A4F-962F-3DDD746CAB93 Q37719385-CC0B7A8E-4D09-4B47-95A0-B23DD52D61E8 Q37806982-D40721AF-92A4-4B15-905B-3E4A63B6A50B Q37845227-A43E4529-31E5-4E4C-9049-A10DA3AE8CC0 Q37917782-60E35877-5247-416B-BDF8-942941DB318E Q37926893-544B18C7-FEB3-4112-9736-622A64E742B1 Q37952823-F28D4D56-37B1-4EC2-99B2-20DA01EAB6E8 Q37956206-91312CC4-0EDB-476D-90A1-A6F100060F9A Q38154175-D25BF806-47B7-499D-ABC0-6C24BB218531 Q38242739-B6E24C0A-E9D0-4543-949A-B272C842E0C5 Q38536898-A3FE5403-6BF9-4B66-BAFE-3FA62A33F201 Q40562486-CC98CB09-1473-41BC-8882-2E0D52E4392C Q43053801-367D1023-7519-479A-ACDA-93DF78D692CF Q43197092-C220AB07-6A29-49DC-9C70-82BC1EFB616A Q45238388-70CA4CD2-5ECE-4A47-A8D3-994B939E1876 Q45252599-F9A807D1-8A91-4FC5-ADDD-E48731E00E06 Q45918280-98A5D024-7526-4407-86FF-9010C253F9EB Q46015738-C911E682-A119-4DD8-8765-757631CD36AC

P2860

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

http://www.wikidata.org/entity/Q47301630

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

@en

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

@nl

type

label

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

@en

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

@nl

prefLabel

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

@en

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

@nl

P1433

Q47301630-79EFA0C8-198D-4365-809A-44C3702818B0

P1476

Q47301630-45AF2EB1-45CD-4F28-89D5-E5AED07EF4E9

P2093

Q47301630-76EBE566-D649-4C53-9FBC-E33D79ED2656

Q47301630-995FE8F6-FB7D-4A40-825D-6DE41BAB6096

Q47301630-DBBFF371-A3D2-45FD-A688-7E793B904E9D

Q47301630-FDB130DD-649B-4C84-BFE8-D83B79477675

P2860

Q47301630-16044039-E3E7-40BC-825B-6D6C85347410

Q47301630-230BC362-8A2B-4297-91E7-918264075176

Q47301630-24FC135D-D76C-40BD-ABDE-58DD6E8239C0

Q47301630-2B0A81E8-9F9E-4CF4-974A-3A268BCEA607

Q47301630-3AAA5E24-9D6D-41AA-8752-EA712678E707

Q47301630-40D634A1-CA84-4C7C-B332-20F60B530087

Q47301630-42CA7721-0DFA-4734-A532-1FB66C0C6E9C

Q47301630-4D232347-F382-4427-8516-327802EB7DA6

Q47301630-5A98A905-2DAA-4540-A2DC-B3A8C5C12D96

Q47301630-5F11AFF5-B22C-4F27-8100-96036362C376

P304

Q47301630-476450E6-D448-4766-9FAF-C428E1522BD0

P31

Q47301630-48119B15-B78D-49A6-929F-9F362ED1BED3

Q47301630-c8055775-0fff-4ba8-b02a-c423e0ccc422

P356

Q47301630-6F292DD1-D4AB-478E-A9BF-9A6E1FE0534E

P433

Q47301630-2D603CE7-FCA9-43E5-A77B-34A9AC1ACA19

P478

Q47301630-F8E811A7-D079-4DA3-AE6A-E3F44FAB0F19

P577

Q47301630-D2EB1E95-D499-4A59-BC16-3598F133BACE

P698

Q47301630-EC9BFFFB-4D9F-497E-8755-75E204E72C01

P921

Q47301630-45FBF0D4-0496-4B47-AC77-EE02D6B07D25

P356

S1461145707007547

P1433

The International Journal of Neuropsychopharmacology

P1476

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis.

@en

P2093

Andrea de Bartolomeis

http://www.w3.org/2001/XMLSchema#string

Daniel J Mueller

http://www.w3.org/2001/XMLSchema#string

James L Kennedy

http://www.w3.org/2001/XMLSchema#string

Vincenzo De Luca

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Meta-analysis in clinical trials

A prospective study of holiday weight gain

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.

Bodyweight gain with atypical antipsychotics. A comparative review.

Pharmacogenetics of antipsychotic-induced weight gain.

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

Pharmacogenetics as a tool in the therapy of schizophrenia.

P304

697-704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1461145707007547

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17291373

http://www.w3.org/2001/XMLSchema#string

P921